Exact Sciences Corporation
Clinical trials sponsored by Exact Sciences Corporation, explained in plain language.
Molecular diagnostics company focused on cancer screening and detection.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Swab test could spot hidden uterine cancer early
Diagnosis Recruiting nowThis study is collecting vaginal fluid samples from 4,200 people to develop a new test for endometrial cancer. Participants include those with abnormal uterine bleeding or a recent endometrial cancer diagnosis. The goal is to find biomarkers that could lead to a simple, non-invas…
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Can a simple blood test spot cancer early? 25,000 volunteers help find out
Diagnosis Recruiting nowThis registry study is testing a blood test designed to detect multiple types of cancer early by looking for DNA and protein changes linked to cancer. Researchers will follow 25,000 people aged 50 to 80 who take the test and any follow-up imaging. The goal is to see how well the …
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Blood test may predict breast cancer return after chemo
Knowledge-focused Recruiting nowThis study is testing a new blood test that looks for tiny bits of tumor DNA to see if it can predict whether high-risk early breast cancer will come back after chemotherapy. About 1,800 people with early-stage breast cancer who are about to start chemo will give blood and tissue…
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC